Can-Fite BioPharma Ltd. Quarterly Operating Lease, Liability, Noncurrent in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Can-Fite BioPharma Ltd. quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q4 2019 to Q4 2023.
  • Can-Fite BioPharma Ltd. Operating Lease, Liability, Noncurrent for the quarter ending December 31, 2023 was $13K, a 7.14% decline year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $13K -$1K -7.14% Dec 31, 2023 20-F 2024-03-28
Q2 2023 $22K -$18K -45% Jun 30, 2023 6-K 2023-08-31
Q4 2022 $14K -$57K -80.3% Dec 31, 2022 20-F 2024-03-28
Q2 2022 $40K +$15K +60% Jun 30, 2022 6-K 2022-08-25
Q4 2021 $71K +$47K +196% Dec 31, 2021 20-F 2023-03-30
Q2 2021 $25K +$3K +13.6% Jun 30, 2021 6-K 2021-08-26
Q4 2020 $24K -$15K -38.5% Dec 31, 2020 20-F 2022-03-24
Q2 2020 $22K Jun 30, 2020 6-K 2020-08-27
Q4 2019 $39K Dec 31, 2019 20-F 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.